A global push to tackle neglected diseases such as malaria and tuberculosis is gathering steam, . . . largely because of an influx of charity money to subsidize the work of the drug companies. Though this push is only five years old, many of the projects are reaching advanced stages, and a string of new products could get licensed by 2010. (Washington Post, Tuesday)
Think how much more of this would go on in a fully free society.
FEE Timely Classic
Why Not Private Charity? by Robert Awenius